ViaFarma Solutions Request quote

ViaFarma service

Pharmacovigilance & Post-Approval

Practical pharmacovigilance, safety and post-approval support for products marketed in the UAE and GCC.

Safety oversight

We help companies establish practical processes for safety information, case handling, escalation and regulatory communication within the agreed scope.

Product continuity

Post-approval planning connects safety, variations, renewals and risk management so products can remain compliant throughout their lifecycle.

Questions from manufacturing and regulatory teams

What should an MAH agree with its local partner before launch?

Confirm the applicable safety reporting obligations and timelines with the relevant authority. ViaFarma recommends documenting who receives and escalates cases, how records are reconciled, and how both parties confirm handovers when teams or distributors change.

Review Your Local Safety Handover Plan

How we start

Share the product or scope, target authority or market, and desired timing. We will return with an initial assessment and clear next steps.

Is your product ready for the UAE — beyond registration?

Free UAE Market-Entry Quick Check

Planning to introduce a pharmaceutical, medical device, healthcare or cosmetic product in the UAE? Send us your product and current approval status. The initial review can cover classification and pathway, regulatory readiness, obvious dossier gaps, market-entry considerations and a recommended next step. It is not a complete market-access assessment.

Send Product for Quick Check Book a 15-Minute ConsultationWe will review the information you send to identify the most appropriate first step.

Our approach

A clear path from assessment to execution.

01

Assess

We understand the product, objective and target authority or market.

02

Plan

We define priorities, requirements and the practical next step.

03

Deliver

We coordinate the agreed work, documents and communication.

04

Support

We stay engaged through follow-up and the project lifecycle.